the neurobiology of free will in nora d. volkow, m.d. director national institute on drug abuse nora...

21
The Neurobiology of Free Will In Nora D. Volkow, M.D. Director National Institute on Drug Abuse

Upload: carmel-pitts

Post on 17-Jan-2016

220 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: The Neurobiology of Free Will In Nora D. Volkow, M.D. Director National Institute on Drug Abuse Nora D. Volkow, M.D. Director National Institute on Drug

The Neurobiology of Free Will In The Neurobiology of Free Will In

Nora D. Volkow, M.D.Director

National Institute on Drug Abuse

Nora D. Volkow, M.D.Director

National Institute on Drug Abuse

Page 2: The Neurobiology of Free Will In Nora D. Volkow, M.D. Director National Institute on Drug Abuse Nora D. Volkow, M.D. Director National Institute on Drug

Dopamine Neurotransmission

VTA/SNVTA/SNnucleus accumbensnucleus accumbens

frontalcortexfrontalcortex

00100100200200300300400400500500600600700700800800900900

1000100011001100

00 11 22 33 44 5 hr5 hrTime After AmphetamineTime After Amphetamine

% o

f B

as

al

Re

lea

se

% o

f B

as

al

Re

lea

se

AMPHETAMINEAMPHETAMINE

00

5050

100100

150150

200200

00 6060 120120 180180Time (min)Time (min)

% o

f B

asal

Re

lea

se%

of

Bas

al R

ele

ase

EmptyEmptyBoxBox FeedingFeeding

Di Chiara et al.Di Chiara et al.

FOODFOOD

Page 3: The Neurobiology of Free Will In Nora D. Volkow, M.D. Director National Institute on Drug Abuse Nora D. Volkow, M.D. Director National Institute on Drug

TYR OSINE

DA

DOPA

DA

DA

DA

DA

TYR OSINE

DA

DOPA

DA

DA

DA

D AD A D A D A

D AD AD A

methylphenidate

RRRRRR

-10 0 10 20 30 40-20246810

Self-Reports

(0-10)

Change in DopamineBmax/kd (Placebo - MP)

“High”

DA and Drug Reinforcement

racloprideraclopride

DA DA

DA initiates and maintains responses to salient stimuli such as drugs

DA initiates and maintains responses to salient stimuli such as drugs

Volkow et al., JPET 291(1):409-415, 1999. Volkow et al., JPET 291(1):409-415, 1999.

Page 4: The Neurobiology of Free Will In Nora D. Volkow, M.D. Director National Institute on Drug Abuse Nora D. Volkow, M.D. Director National Institute on Drug

NAccNAccVPVP

REWARDREWARD• In laboratory animals repeated exposure to the drug results in enhanced responses to it (sensitization) that have been hypothesized to underlie

addiction. • Here we tested if, in humans

addicted to cocaine, there is an enhancement of DA release and of the reinforcing effects of the drug.

• In laboratory animals repeated exposure to the drug results in enhanced responses to it (sensitization) that have been hypothesized to underlie

addiction. • Here we tested if, in humans

addicted to cocaine, there is an enhancement of DA release and of the reinforcing effects of the drug.

For this purpose we compared the changes in DA and the behavioral effects of intravenous MP between cocaine abusers (n=20) and controls (n=20)

For this purpose we compared the changes in DA and the behavioral effects of intravenous MP between cocaine abusers (n=20) and controls (n=20)

1. Reward Circuit 1. Reward Circuit

Page 5: The Neurobiology of Free Will In Nora D. Volkow, M.D. Director National Institute on Drug Abuse Nora D. Volkow, M.D. Director National Institute on Drug

00

22

44

66

88

1010

ControlsControls AbusersAbusers

PlaceboPlaceboMPMP

Sel

f R

epor

t C

ravi

ng

Sel

f R

epor

t C

ravi

ng

(0-1

0)(0

-10)

00

22

44

66

88

1010

ControlsControls AbusersAbusers

Sel

f R

epor

tS

elf

Rep

ort

(0-1

0)(0

-10)

Self Reports of Drug Effects After iv MP in Controls and in

Cocaine Abusers

Self Reports of Drug Effects After iv MP in Controls and in

Cocaine Abusers

P < 0.001P < 0.001

P <0.001P <0.001

High Craving

Cocaine abusers showed decreased drug induced increases in rewarding responses and enhanced drug craving

Cocaine abusers showed decreased drug induced increases in rewarding responses and enhanced drug craving

Volkow et al., Nature 386:830-833, 1997.Volkow et al., Nature 386:830-833, 1997.

Page 6: The Neurobiology of Free Will In Nora D. Volkow, M.D. Director National Institute on Drug Abuse Nora D. Volkow, M.D. Director National Institute on Drug

0

5

10

15

20

25

30

35

% C

han

ge B

max

/Kd

% C

han

ge B

max

/Kd

Controls(n = 20)Controls(n = 20)

Abusers (n = 20)Abusers (n = 20)

P < 0.003P < 0.003

Cocaine abusers showed decreased DA increases and

reduced reinforcing responses to MP

Cocaine abusers showed decreased DA increases and

reduced reinforcing responses to MP

Normal Control

Cocaine Abuser

Placebo MP

Methylphenidate-induced Increases in Striatal DA in Controls and in

Cocaine Abusers

Methylphenidate-induced Increases in Striatal DA in Controls and in

Cocaine Abusers

21%

9%

Volkow et al., Nature 386:830-833, 1997.Volkow et al., Nature 386:830-833, 1997.

Page 7: The Neurobiology of Free Will In Nora D. Volkow, M.D. Director National Institute on Drug Abuse Nora D. Volkow, M.D. Director National Institute on Drug

HippHipp

AmygAmyg MEMORY/LEARNING MEMORY/

LEARNING

Philipps et al Nature 422, 614-618Philipps et al Nature 422, 614-618

In training the cue was paired with cocaine

In training the cue was not paired with cocaine

2. Memory circuit • In rats when a neutral stimulus is repeatedly paired with the drug (conditioned), it elicits DA increases and reinstates drug self- administration.

• In rats when a neutral stimulus is repeatedly paired with the drug (conditioned), it elicits DA increases and reinstates drug self- administration.

Here we tested if conditioned stimuli increase DA in

addicted subjects and its relationship to drug craving

Here we tested if conditioned stimuli increase DA in

addicted subjects and its relationship to drug craving

DA

Rel

ease

NA

c

Auditory cue

Page 8: The Neurobiology of Free Will In Nora D. Volkow, M.D. Director National Institute on Drug Abuse Nora D. Volkow, M.D. Director National Institute on Drug

[11C]Raclopride Binding In Cocaine Abusers (n=18) Viewing a Neutral and a Cocaine-Cue Video

[11C]Raclopride Binding In Cocaine Abusers (n=18) Viewing a Neutral and a Cocaine-Cue Video

Viewing a video of cocaine scenes decreased specific binding of [11C]raclopride presumably from DA increases

Viewing a video of cocaine scenes decreased specific binding of [11C]raclopride presumably from DA increases

Neutral video

Volkow et al. J Neuroscience 2006.Volkow et al. J Neuroscience 2006.

Page 9: The Neurobiology of Free Will In Nora D. Volkow, M.D. Director National Institute on Drug Abuse Nora D. Volkow, M.D. Director National Institute on Drug

Cue-induced increases in DA were associated with cravingCue-induced increases in DA were associated with craving

P < 0.002

% Change Bmax/Kd

-0.50

0.0

0.50

1.0

1.5

2.0

2.5

-40-30-20-100102030

Putamen

Ch

ange

in C

ravi

ng

(Pre

- P

ost)

Relationship between Cue-Induced Decreases in [11C]raclopride Binding and Cocaine Craving

Relationship between Cue-Induced Decreases in [11C]raclopride Binding and Cocaine Craving

Cau

date

Cau

date

Pu

tam

enP

uta

men

2.002.00

2.502.50

3.003.00

3.503.50

NeutralNeutralCocaine-CuesCocaine-Cues

Bm

ax/K

dB

max

/Kd

P < 0.05P < 0.05

P < 0.01P < 0.01

Volkow et al J Neuroscience 2006.Volkow et al J Neuroscience 2006.

Page 10: The Neurobiology of Free Will In Nora D. Volkow, M.D. Director National Institute on Drug Abuse Nora D. Volkow, M.D. Director National Institute on Drug

We assessed the relationship between DA markers and frontal activity in cocaine (n=20) and in

methampethamine abusers (n =20) and controls

We assessed the relationship between DA markers and frontal activity in cocaine (n=20) and in

methampethamine abusers (n =20) and controls

3.Motivation & Executive Control Circuits3.Motivation & Executive Control Circuits ACGACG

OFCOFCSCCSCC

INHIBITORY CONTROL

INHIBITORY CONTROL

EXECUTIVEFUNCTIONEXECUTIVEFUNCTION

PFCPFC

MOTIVATION/DRIVE

MOTIVATION/DRIVE

Here we tested if, in addicted subjects, changes in DA function were linked with disruption of frontal activity as assessed by brain glucose metabolism.

Here we tested if, in addicted subjects, changes in DA function were linked with disruption of frontal activity as assessed by brain glucose metabolism.

DA is involved not only with reward and prediction of reward but also with motivation and executive function via its regulation of frontal activity.

Page 11: The Neurobiology of Free Will In Nora D. Volkow, M.D. Director National Institute on Drug Abuse Nora D. Volkow, M.D. Director National Institute on Drug

AnatomyAnatomy DA

DA

DA

DA DA DA

DA

signal

Dopamine SynapseDopamine Synapse

DA D2 ReceptorsDA D2 Receptors

MetabolismMetabolism

Dopamine Measures ObtainedDopamine Measures Obtained

Adapted from: Volkow et al., J Clin Invest 111(10):1444-1451, 2003. Adapted from: Volkow et al., J Clin Invest 111(10):1444-1451, 2003.

Page 12: The Neurobiology of Free Will In Nora D. Volkow, M.D. Director National Institute on Drug Abuse Nora D. Volkow, M.D. Director National Institute on Drug

normal subject

cocaine abuser (1 month post)

cocaine abuser (4 months post)

Effect of Cocaine Abuse on Dopamine D2 Receptors

Volkow et al., Synapse 14(2): 169-177, 1993. Volkow et al., Synapse 14(2): 169-177, 1993.

Page 13: The Neurobiology of Free Will In Nora D. Volkow, M.D. Director National Institute on Drug Abuse Nora D. Volkow, M.D. Director National Institute on Drug

1.51.5

22

2.52.5

33

3.53.5

44

4.54.5

1515 2020 2525 3030 3535 4040 4545 5050

DA

D2

Rec

epto

rsD

A D

2 R

ecep

tors

(Rat

io I

ndex

)(R

atio

Ind

ex)

DA D2 Receptors in Controls and in Cocaine Abusers (NMS)

DA D2 Receptors in Controls and in Cocaine Abusers (NMS)

Age (years)Age (years)

2020 2525 3030 3535 4040 4545 50501.61.6

1.81.8

22

2.22.2

2.42.4

2.62.6

2.82.8

33

3.23.2

Bm

ax/K

dB

max

/Kd

Normal ControlsNormal ControlsCocaine AbusersCocaine Abusers

Volkow et al., Neuropsychopharmacology 14(3):159-168, 1996.Volkow et al., Neuropsychopharmacology 14(3):159-168, 1996.

Page 14: The Neurobiology of Free Will In Nora D. Volkow, M.D. Director National Institute on Drug Abuse Nora D. Volkow, M.D. Director National Institute on Drug

DA D2 Receptor

Availability

DA D2 Receptor

Availability

CocaineCocaine

AlcoholAlcohol

Reward Circuits

DA

DA

DA

DA DA

DA

Drug AbuserDrug Abuser

DA

DA

DA

DA DA DA

DA

Reward Circuits

DA DA DA DA

DA

Non-Drug AbuserNon-Drug Abuser

HeroinHeroin

MethMeth

Dopamine D2 Receptors are Lower in Addiction

controlcontrol addictedaddictedAdapted from Volkow et al., Neurobiology of Learning andMemory 78:610-624, 2002.

Adapted from Volkow et al., Neurobiology of Learning andMemory 78:610-624, 2002.

Page 15: The Neurobiology of Free Will In Nora D. Volkow, M.D. Director National Institute on Drug Abuse Nora D. Volkow, M.D. Director National Institute on Drug

2nd D2R Vector

2nd D2R Vector

Effects of Tx with an Adenovirus Carrying a DA D2 Receptor Gene into

NAc in DA D2 Receptors

Effects of Tx with an Adenovirus Carrying a DA D2 Receptor Gene into

NAc in DA D2 Receptors

00

1010

2020

3030

4040

5050

6060

Per

cen

t C

han

ge in

D2R

Per

cen

t C

han

ge in

D2R

44 66 88 1010 2424

p < 0.0005

p < 0.0005

p < 0.005

p < 0.10

p < 0.005

1st D2R Vector

1st D2R Vector

00

Null Vector

Null Vector

-100-100

-80-80

-60-60

-40-40

-20-20

0 0

Time (days)Time (days)44 66 88 1010 2424

p < 0.001p < 0.001

% Change in Alcohol Intake

% Change in Alcohol Intake

p < 0.001p < 0.001

p < 0.001p < 0.001

p < 0.01p < 0.01p < 0.01p < 0.01

00

Overexpression of DA D2 receptors reduces alcoholself-administration

Overexpression of DA D2 receptors reduces alcoholself-administration

Thanos, PK et al., J Neurochem, 78, pp. 1094-1103, 2001.Thanos, PK et al., J Neurochem, 78, pp. 1094-1103, 2001.

DA DADA

DA DA

DA

DA

DA

Page 16: The Neurobiology of Free Will In Nora D. Volkow, M.D. Director National Institute on Drug Abuse Nora D. Volkow, M.D. Director National Institute on Drug

Brain Glucose Metabolism in Cocaine Abusers (n=20) and Controls

(n=23)

Brain Glucose Metabolism in Cocaine Abusers (n=20) and Controls

(n=23)

40

45

50

55

60

ControlsControls AbusersAbusers

mic

rom

ol/1

00g/

min

mic

rom

ol/1

00g/

min

40

45

50

55

60

ControlsControls AbusersAbusers

mic

rom

ol/1

00g/

min

mic

rom

ol/1

00g/

min

CGCG

OFCOFC

CG

P < 0.005P < 0.005

P < 0.01P < 0.01

Volkow et al., AJP 156:19-26, 1999.Volkow et al., AJP 156:19-26, 1999.

Page 17: The Neurobiology of Free Will In Nora D. Volkow, M.D. Director National Institute on Drug Abuse Nora D. Volkow, M.D. Director National Institute on Drug

Correlations Between D2 Receptors in Striatum and Brain Glucose

Metabolism

Striatum

CG

PreF

OFC

30

40

50

60

70

80

90

2.9 3 3.1 3.2 3.3 3.4 3.5 3.6

OFC

OFC

umol/100gr/min

umol/100gr/min

DA D2 ReceptorsDA D2 Receptors (Bmax/kd)(Bmax/kd)

3035404550556065

1.8 2 2.2 2.4 2.6 2.8 3 3.2 3.4DA D2 Receptors (Ratio Index)DA D2 Receptors (Ratio Index)

OFC

OFC

umol/100g/min

umol/100g/min

r = 0.7, p < 0.001

Cocaine Abusers

r = 0.7, p < 0.005

METHAbusers

control cocaine abuser

Volkow et al., Synapse 14(2):169-177, 1993.Volkow et al., Synapse 14(2):169-177, 1993.

Volkow et al., AJP 158(3):377-382, 2001.Volkow et al., AJP 158(3):377-382, 2001.

Page 18: The Neurobiology of Free Will In Nora D. Volkow, M.D. Director National Institute on Drug Abuse Nora D. Volkow, M.D. Director National Institute on Drug

0.9000.9000.9500.9501.001.001.051.051.101.101.151.151.201.201.251.251.301.30

4.04.0 4.24.2 4.44.4 4.64.6 4.84.8 5.05.0

OF

CO

FC

Rel

ativ

e m

etab

olis

mR

elat

ive

met

abol

ism

0.7500.750

0.8000.800

0.8500.850

0.9000.900

0.9500.950

1.001.00

1.051.05

4.04.0 4.24.2 4.44.4 4.64.6 4.84.8 5.05.0

CG

CG

Rel

ativ

e m

etab

olis

mR

elat

ive

met

abol

ism

DA D2 Receptors and Relationship to Brain Metabolism in Subjects with Family History for Alcoholism

DA D2R were associated with metabolic activity in OFC, CG and dorsolateral prefrontal cortex

DA D2R were associated with metabolic activity in OFC, CG and dorsolateral prefrontal cortex

D2R (Bmax/Kd)D2R (Bmax/Kd)

Correlations between Metabolism and D2R P <0.005

Correlations between Metabolism and D2R P <0.005

Volkow et al. Arch Gen Psychiatry 2006.Volkow et al. Arch Gen Psychiatry 2006.

Page 19: The Neurobiology of Free Will In Nora D. Volkow, M.D. Director National Institute on Drug Abuse Nora D. Volkow, M.D. Director National Institute on Drug

DriveOFCDriveOFC

Saliency NAcSaliency NAc

MemoryAmygdalaMemoryAmygdala

Control CG Control CG

Non-Addicted Brain

Non-Addicted Brain

AddictedBrain

AddictedBrain

STOP STOP

GOGODriveDrive

MemoryMemory

Saliency Saliency

ControlControl

DriveDrive

MemoryMemory

Saliency Saliency

Adapted from: Volkow et al., J Clin Invest 111(10):1444-1451, 2003. Adapted from: Volkow et al., J Clin Invest 111(10):1444-1451, 2003.

Page 20: The Neurobiology of Free Will In Nora D. Volkow, M.D. Director National Institute on Drug Abuse Nora D. Volkow, M.D. Director National Institute on Drug

Medications for Relapse PreventionMedications for Relapse Prevention

Interfere with conditioned memories (craving)Interfere with conditioned memories (craving)

Counteract stress responses that lead to relapseCounteract stress responses that lead to relapse

Strengthen reinforcing effects of non-drug reinforcers

Strengthen reinforcing effects of non-drug reinforcers

Strengthen inhibitory controlStrengthen inhibitory control

Strengthen prefrontal-striatal communicationStrengthen prefrontal-striatal communication

Addicted Brain

Drive

Control

Saliency

Memory

GOSTOPSaliency Drive

Control

Memory

Non-Addicted Brain

Adapted from: Volkow et al., J Clin Invest 111(10):1444-1451, 2003. Adapted from: Volkow et al., J Clin Invest 111(10):1444-1451, 2003.

Page 21: The Neurobiology of Free Will In Nora D. Volkow, M.D. Director National Institute on Drug Abuse Nora D. Volkow, M.D. Director National Institute on Drug

Brookhaven PET Group

F. Telang, R. MacGregor, P. Carter, D. Schlyer, C. Shea, J. Gatley, S. Dewey, C. Redvanly, P. King

L. Caligiuri, G-J Wang, M. Franceschi, Y-S Ding, J. Logan, N. Volkow, J. Fowler, R. Ferrieri, C. Wong

(not shown) D. Alexoff, C. Felder, N. Pappas, D. Franceschi, N. Netusil, V. Garza, R. Carciello, D. Warner, M. Gerasimov

F. Telang, R. MacGregor, P. Carter, D. Schlyer, C. Shea, J. Gatley, S. Dewey, C. Redvanly, P. King

L. Caligiuri, G-J Wang, M. Franceschi, Y-S Ding, J. Logan, N. Volkow, J. Fowler, R. Ferrieri, C. Wong

(not shown) D. Alexoff, C. Felder, N. Pappas, D. Franceschi, N. Netusil, V. Garza, R. Carciello, D. Warner, M. Gerasimov